D
Deffai provides an AI-powered platform for life sciences companies to navigate the FDA regulatory lifecycle efficiently. The system uses machine learning, informed by former FDA expertise, to offer pathway analysis, submission intelligence, and meeting preparation tools. This accelerates regulatory timelines by automating document review and flagging potential submission deficiencies before agency submission.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Deffai offers an AI-native platform and expert consulting to streamline regulatory strategy for life sciences companies developing biologics, drugs, and devices. The platform automates document drafting and anticipates FDA feedback to optimize clinical timelines and market entry. This integrated approach provides teams with scalable support grounded in FDA guidance for successful product approvals.